Strategic advisory for complex therapy access
MedScore helps pharmaceutical companies, healthcare service providers, and Market Access organizations design practical frameworks for unlicensed medicines supply and managed access programs.
Full Managed Access Cycle Strategic Consulting
Designing scalable Access Frameworks that seamlessly transition from Expanded Access Programs (EAPs) into Managed Access Programs (MAPs), Licensing, and Commercialization Strategies.
Services
Practical advisory for sustainable access models.
Strategy & Governance
Governance, compliance, and operating frameworks for sustainable therapy access.
Managed Access Pathways
Support across expanded access, extended access, managed access programs, licensing and commercialization.
Country-Specific Access Planning
Import licensing, Importer of Record structures, customs clearance coordination, and local logistics oversight.
Partner & Supplier Mapping
Identification and qualification of manufacturers, wholesalers, service providers, and downstream stakeholders.
Approach
Built for regulated, high-stakes environments.
MedScore combines strategic design with operational detail: stakeholder mapping, regulatory pathway assessment, quality expectations, import structures, logistics planning, and governance documentation.
The focus is not theoretical consultancy. It is the creation of usable frameworks that help teams move from opportunity to compliant execution.
Typical engagements
Short, focused assignments or longer advisory support depending on the access challenge.
Let’s structure the access pathway.
Contact MedScore to discuss strategic advisory support for managed access, unlicensed medicine pathways, or cross-border therapy access operations.